The Meteoric Rise of SNPK
The stock has been going up 10% or more everyday.
The stock could take a big hit if it couldn't pass through
the psychologically very, very critical milestone of One
Billion Dollar!
Two important things to watch:
1). If the stock fails to achieve $1 Billion Market Cap.
2). Fails to cross the critical $2.50 hurdle today.
It might pause right here and/or you may see profit taking.
To our Members and Followers: you heard it here first, make a note to yourself.
Happy trading!
DailyStockDeals.com
Wednesday, April 18, 2012
Monday, April 16, 2012
OxBridgeResearch - stock market news - Vitamin stock on Steriods! SNPK, Sunpeaks Venture, Clotamin
This little Vitamin supplement stock has been on Steroids! The stock has risen dramatically from @ 40 cents to $1.80. The company is now worth a whopping $760 Million Dollars! How far the stock could go and for how long? Find out Today!
For our Busy Readers, we present A Quick Snap Shot of SNPK!
SNPK 's stellar announcements:
Latest News: SNPK signs advertising and promotion agreement with another major sports team. Clotamin to be sold in all 240 Walgreens locations across Arizona!
SNPK entered agreement with a UK based heathcare firm to introduce Clotamin to the UK and European Union countries. This was another great move by the company to grab market share in countries across the pond!
SNPK receives $9 price target, and STRONG BUY recommendation by Small Cap Investment Research.
SNPK (in a first move to expand to international markets) announced an LOI to export Clotamin to top pharmacies in Russia. The initial roll out will be into 414 Imperia-Pharma locations in the country. This news is absolutely gigantic, and will attract foreign investors' interest in SNPK!
SNPK Inks Sponsorship and Marketing Agreement with Portland Trail Blazers, Clotamin to be sold at 79 Walgreens locations throughout Oregon and Southern Washington. This news is very welcome as it shows us that the company is not only expanding rapidly in the south east, but also throughout the country as it looks to gain critical mass for Clotamin!
SNPK announced that the AACSA could carry Clotamin into up to 11,200 stores in the next 36 months! With 1,200 stores "trial" to start shortly!
SNPK announced a sales and marketing agreement with Acosta is a major milestone for SNPK because Acosta has developed relationships with the nation's largest retailers. With $50 billion in system-wide sales and nearly 20,000 associates that monthly call on over 100,000 retail stores per month Acosta is a key player in the industry and has a monster list of clients that include Walmart, Campbell's, Procter & Gamble!
SNPK announced that Clotamin will be available at 57 Winn-Dixie stores across South Florida. This news is absolutely fantastic because the Winn-Dixie group (with parent company) operates almost 1,000 stores throughout America and after rolling out Clotamin into the initial 57 stores the product may have a great chance of being sold at additional locations in their network. For those of you who don't know the Winn-Dixie stores had over $7 billion in revenue in 2010 so this announcement is gigantic.
SNPK announced that Clotamin is now available online nationwide at Walgreen's. We aren't even going to comment about this announcement as everyone knows fairly well how enormous Walgreens is and just how huge this news is. In fact you can go to Walgreens online right now and order Clotamin if you need it! It's only 25.99!
SNPK announced that Clotamin will be sold at Tropical supermarkets in South Florida.
SNPK announced that Clotamin will be sold at Bravo supermarkets in South Florida.
SNPK announced that Clotamin will be sold at approximately 70 Drug Mart locations in Ohio. Being carried by Drug Mart in Ohio is amazing for SNPK as it begins expanding outside of the Florida and into retailers nationwide.
SNPK 's clotamin will also be sold at over 34 Sedano's stores in Florida. Sedano's is the No. 1 Hispanic owned retailer in the US, and is also the largest member of the Associated Grocers of Florida. This in itself is a huge achievement for Clotamin as it pierces in the Latin American market.
SNPK announced that Clotamin will be sold at Navarro Discount Pharmacies.
SNPK announced that Dakota Drug Inc. is a distributor for Clotamin. This milestone is very important as these key distributors can dramatically increase Clotamin's presence in the marketplace.
Courtesy: Ox of Wall street
OxBridgeResearch.com
For our Busy Readers, we present A Quick Snap Shot of SNPK!
SNPK 's stellar announcements:
Latest News: SNPK signs advertising and promotion agreement with another major sports team. Clotamin to be sold in all 240 Walgreens locations across Arizona!
SNPK entered agreement with a UK based heathcare firm to introduce Clotamin to the UK and European Union countries. This was another great move by the company to grab market share in countries across the pond!
SNPK receives $9 price target, and STRONG BUY recommendation by Small Cap Investment Research.
SNPK (in a first move to expand to international markets) announced an LOI to export Clotamin to top pharmacies in Russia. The initial roll out will be into 414 Imperia-Pharma locations in the country. This news is absolutely gigantic, and will attract foreign investors' interest in SNPK!
SNPK Inks Sponsorship and Marketing Agreement with Portland Trail Blazers, Clotamin to be sold at 79 Walgreens locations throughout Oregon and Southern Washington. This news is very welcome as it shows us that the company is not only expanding rapidly in the south east, but also throughout the country as it looks to gain critical mass for Clotamin!
SNPK announced that the AACSA could carry Clotamin into up to 11,200 stores in the next 36 months! With 1,200 stores "trial" to start shortly!
SNPK announced a sales and marketing agreement with Acosta is a major milestone for SNPK because Acosta has developed relationships with the nation's largest retailers. With $50 billion in system-wide sales and nearly 20,000 associates that monthly call on over 100,000 retail stores per month Acosta is a key player in the industry and has a monster list of clients that include Walmart, Campbell's, Procter & Gamble!
SNPK announced that Clotamin will be available at 57 Winn-Dixie stores across South Florida. This news is absolutely fantastic because the Winn-Dixie group (with parent company) operates almost 1,000 stores throughout America and after rolling out Clotamin into the initial 57 stores the product may have a great chance of being sold at additional locations in their network. For those of you who don't know the Winn-Dixie stores had over $7 billion in revenue in 2010 so this announcement is gigantic.
SNPK announced that Clotamin is now available online nationwide at Walgreen's. We aren't even going to comment about this announcement as everyone knows fairly well how enormous Walgreens is and just how huge this news is. In fact you can go to Walgreens online right now and order Clotamin if you need it! It's only 25.99!
SNPK announced that Clotamin will be sold at Tropical supermarkets in South Florida.
SNPK announced that Clotamin will be sold at Bravo supermarkets in South Florida.
SNPK announced that Clotamin will be sold at approximately 70 Drug Mart locations in Ohio. Being carried by Drug Mart in Ohio is amazing for SNPK as it begins expanding outside of the Florida and into retailers nationwide.
SNPK 's clotamin will also be sold at over 34 Sedano's stores in Florida. Sedano's is the No. 1 Hispanic owned retailer in the US, and is also the largest member of the Associated Grocers of Florida. This in itself is a huge achievement for Clotamin as it pierces in the Latin American market.
SNPK announced that Clotamin will be sold at Navarro Discount Pharmacies.
SNPK announced that Dakota Drug Inc. is a distributor for Clotamin. This milestone is very important as these key distributors can dramatically increase Clotamin's presence in the marketplace.
Courtesy: Ox of Wall street
OxBridgeResearch.com
Saturday, April 14, 2012
Ecosphere Technologies, ESPH.OB, Summary, Profile
Ecosphere Technologies | ESPH.OB | Summary | Profile
Ecosphere Technologies, ESPH.OB, is a diversified engineering and technology company, engaged in clean technologies and services.
The company designs and builds mobile water filtration equipment, waste water treatment and provides water recycling services to the energy exploration companies.
Ozonix®
The company's patented Ozonix technology is primarily used by the gas and oil companies for treatment and recycling of water used in fracking. The technology eliminates, bacteria and reduces scaling, eliminating the need to dispose the contaminated water. This process helps Oil&Gas companies save money and improve productivity.
Mobile, High-Volume Fluid Reclamation:
Ozonix® Eliminates Liquid Chemical Biocides
Provides Rapid On-Site Water Reclamation
Oxidizes Contaminates, Killing Bacteria and Destroying Bacteria Cell Walls On-the-Fly
Eliminates Costly Biocides and Reduces Scale Inhibitors Needed for Corrosion Control
Eliminates the Costs Associated with Waste Separation, Transportation & Disposal
High-Volume Water Treatment Capabilities allow for Quick Turnaround Time and Increased Utilization
Self-Contained Ozonix® Systems offer Minimal Mobilization and Demobilization Arrangements
Environmentally Safe, Eliminating Hazardous Waste Byproducts and Residual Pollutants
Ozonix® Preserves Natural Water Resources Minimizing Customers' Carbon Footprints
The Shale Gas industry is expanding at a rapid pace, waste water treatment, recycling and chemicals used in the process of fracking is a major environmental concern. The company's has developed a technology that doesn't require any chemicals. The company has a great technology serving the growing need of Oil & GAS, Mining Industries and Municipalities, and an Excellent management team, Keep an eye!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.
Ecosphere Technologies, ESPH.OB, is a diversified engineering and technology company, engaged in clean technologies and services.
The company designs and builds mobile water filtration equipment, waste water treatment and provides water recycling services to the energy exploration companies.
Ozonix®
The company's patented Ozonix technology is primarily used by the gas and oil companies for treatment and recycling of water used in fracking. The technology eliminates, bacteria and reduces scaling, eliminating the need to dispose the contaminated water. This process helps Oil&Gas companies save money and improve productivity.
Mobile, High-Volume Fluid Reclamation:
Ozonix® Eliminates Liquid Chemical Biocides
Provides Rapid On-Site Water Reclamation
Oxidizes Contaminates, Killing Bacteria and Destroying Bacteria Cell Walls On-the-Fly
Eliminates Costly Biocides and Reduces Scale Inhibitors Needed for Corrosion Control
Eliminates the Costs Associated with Waste Separation, Transportation & Disposal
High-Volume Water Treatment Capabilities allow for Quick Turnaround Time and Increased Utilization
Self-Contained Ozonix® Systems offer Minimal Mobilization and Demobilization Arrangements
Environmentally Safe, Eliminating Hazardous Waste Byproducts and Residual Pollutants
Ozonix® Preserves Natural Water Resources Minimizing Customers' Carbon Footprints
The Shale Gas industry is expanding at a rapid pace, waste water treatment, recycling and chemicals used in the process of fracking is a major environmental concern. The company's has developed a technology that doesn't require any chemicals. The company has a great technology serving the growing need of Oil & GAS, Mining Industries and Municipalities, and an Excellent management team, Keep an eye!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.
OxBridgeResearch.com (DJ Newswires)Yuan trade band expands, US, Europe calls for more
-China will allow the yuan to trade in a wider daily range beginning Monday
--Beijing moving gradually toward a more market-determined exchange-rate regime
--Yuan's trading band against U.S. dollar now 1.0% above and below a daily reference exchange rate, from 0.5% now
--White House calls move 'progress.' Will push for more movement with ultimate goal of reaching 'market value.'
By Esther Fung and Shen Hong `Of DOW JONES NEWSWIRES
SHANGHAI (Dow Jones)--China will allow the yuan to trade in a wider daily range against the U.S. dollar beginning Monday, taking another major but widely-anticipated step to further liberalize its exchange-rate regime and make its currency more market-oriented.
The move received cautious praise by U.S. and international officials, who described the widening as an important step while renewing their calls for further appreciation of the yuan.
The People's Bank of China said Saturday it will widen the yuan's trading band against the U.S. dollar to 1.0% above and below a daily reference exchange rate from 0.5% now. It last expanded the dollar/yuan trading band from 0.3% in May 2007.
The move came at a time when the currency's immediate outlook seems murky and as pressures for the yuan to appreciate have eased substantially after recent data showed that the country's trade has become more balanced, ending a remarkable era of constant, huge trade surpluses as Chinese goods flooded the global market with the help of inexpensive labor and a cheap yuan.
Senior officials, including Premier Wen Jiabao and China's central banker, have hinted strongly on various occasions in recent months that they would let the yuan trade in a wider range as they argued the currency is nearing fair value. The authorities' decision also followed data showing the world's second-largest economy grew at its slowest pace in three years in the first quarter, a development that calls for further policy easing.
The yuan's performance has indeed become significantly more volatile in recent months, suffering waves of heavy selling and on numerous occasions hitting its downside band limit due to concerns about a hard landing for the Chinese economy.
The yuan has depreciated 0.14% against the dollar so far this year and accumulated a gain of 8.3% since Beijing effectively depegged its currency from the greenback in June 2010. The yuan was trading at around 6.3030 to the dollar late Friday. more news
Thursday, April 12, 2012
Buy Sell Penny Stocks (press release) Google splits stock, creates new C shares, A shares retain Voting right
NEW YORK (AP) — Google Inc. has announced plans to issue a new class of stock to existing shareholders, effectively splitting shares 2 to 1. It’s an unusual approach that reflects a desire by Google’s founders to preserve the company’s long-term interests.
Here’s an explanation of the plan:
Q. Why is Google doing this?
A. Google’s current stock structure concentrates voting power with Google’s founders, Larry Page and Sergey Brin, and with Executive Chairman Eric Schmidt. Google is afraid of diluting that power as it issues new shares to employees and to companies that it acquires through stock purchases. Google says there’s no immediate danger of that happening, but it sees no need to wait. “It’s important to bear in mind that this proposal will only have an effect on governance over the very long term,” Page and Brin wrote in a letter. “It’s just that since we know what we want to do, there’s no reason to delay the decision.”
Q. What does this mean for existing shareholders?
A. Investors typically have Class A stock now. They will be given an equal number of Class C shares, which won’t have any voting power. The value of the Class A stock will be split between the two, so if the stock is trading at $600 when it happens, a Class A share will be worth $300 and a Class C share will be worth $300. Investors will have twice the number of shares they held before, but the total voting power and stock value won’t change. So if Bob owns 100 shares worth $600 each, he will own 200 shares worth $300 each. Bob will still have 100 votes, and the value of all his shares will still be $60,000. Investors will be free to buy and sell shares in either class independently, and the new class will get its own ticker symbol. If Bob sells his 100 Class C shares, he will have 100 votes through the Class A stock, and the shares will be worth $30,000. But if Bob sells his 100 Class A shares, he will have no vote on the Class C stock worth $30,000.
Here’s an explanation of the plan:
Q. Why is Google doing this?
A. Google’s current stock structure concentrates voting power with Google’s founders, Larry Page and Sergey Brin, and with Executive Chairman Eric Schmidt. Google is afraid of diluting that power as it issues new shares to employees and to companies that it acquires through stock purchases. Google says there’s no immediate danger of that happening, but it sees no need to wait. “It’s important to bear in mind that this proposal will only have an effect on governance over the very long term,” Page and Brin wrote in a letter. “It’s just that since we know what we want to do, there’s no reason to delay the decision.”
Q. What does this mean for existing shareholders?
A. Investors typically have Class A stock now. They will be given an equal number of Class C shares, which won’t have any voting power. The value of the Class A stock will be split between the two, so if the stock is trading at $600 when it happens, a Class A share will be worth $300 and a Class C share will be worth $300. Investors will have twice the number of shares they held before, but the total voting power and stock value won’t change. So if Bob owns 100 shares worth $600 each, he will own 200 shares worth $300 each. Bob will still have 100 votes, and the value of all his shares will still be $60,000. Investors will be free to buy and sell shares in either class independently, and the new class will get its own ticker symbol. If Bob sells his 100 Class C shares, he will have 100 votes through the Class A stock, and the shares will be worth $30,000. But if Bob sells his 100 Class A shares, he will have no vote on the Class C stock worth $30,000.
Wednesday, April 11, 2012
Is Sunpeaks Ventures, SNPK.OB, $625 million Valuation justified?
Sunpeak, SNPK, a tiny little 'vitamin' maker/distributor sporting a whopping $625 million dollars in market cap. All we have seen so far is a constant stream of press releases, announcing LOI from Russia and availability of vitamins at well known stores nationwide.
The company has not provided any sales figures yet! It would be very interesting to see the numbers match the hype.
The company has not provided any sales figures yet! It would be very interesting to see the numbers match the hype.
Subscribe to:
Posts (Atom)